Corporate Home Page – MSD Animal Health
  • About us
    • Featured Stories
    • Our People
    • History
    • Leader Insights
  • Media
    • News Releases
    • Media Center
    • Company Statements for Media
  • Products
    • COMPANION ANIMALS
    • EQUINE
    • SWINE
    • POULTRY
    • RUMINANTS
    • AQUACULTURE
    • DNA TraceBack® | DataLive™
  • Innovation
    • Research & Development
    • Technology Labs
    • Business Development
    • Animal Health Ventures
  • Responsibility
    • Focusing on Sustainability
    • Investing in Tomorrow’s Veterinarians and Associated Professionals
    • PRODUCT QUALITY AND SAFETY ASSESSMENTS
    • Animal Health and Welfare
    • Policies and Positions
  • Careers
  • Contact us
  • msd.com
  • Search

Positive CVMP Opinion Received for NOBILIS MULTRIVA™ 

learn more

FDA Approves BRAVECTO® QUANTUM

12-month parasiticide treatment for dogs offers unrivaled duration of flea and tick protection compared to existing products

learn more

MSD Animal Health Completes Acquisition of Elanco’s Aqua Business

learn more

I Am Animal Health

Grace uses her passion for science to benefit animals and humans. 

learn more

Our Products

Learn more about how our vaccines, medicines and technology solutions help maintain and improve animal health.

learn more

Fostering Innovation

Our team of scientists and researchers are committed to our mission, The Science of Healthier Animals®, and advancing the state of veterinary medicine.

learn more

Committed to Responsibility

At MSD Animal Health, we are dedicated to preserving and improving the health, well-being and performance of animals through science.

learn more

Positive CVMP Opinion Received for NOBILIS MULTRIVA™ 

learn more

FDA Approves BRAVECTO® QUANTUM

12-month parasiticide treatment for dogs offers unrivaled duration of flea and tick protection compared to existing products

learn more

Latest News

European Commission Approves NUMELVI™ (atinvicitinib) Tablets for Dogs

July 24, 2025

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from MSD Animal Health

July 10, 2025

MSD Animal Health Receives Positive Opinion from CVMP for NOBIVAC® L6 and NOBIVAC® LoVo L6 Vaccines for Use in Dogs Against Leptospirosis

June 12, 2025
See all latest news

Social

Connect with Us:

Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

  • Terms of use
  • Forward-Looking statement
  • Privacy
  • Contact us

You are now leaving this website.

By continuing, you will be directed to a site intended for residents outside of the U.S. and Canada.

We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ USA

You are now leaving MSD Animal Health, a website maintained by Merck & Co., Inc., Rahway, NJ USA.

Our company is known as MSD outside the United States and Canada. This link will take you to a website intended for those living outside the United States and Canada.

You are now leaving MSD Animal Health, a website maintained by Merck & Co., Inc., Rahway, NJ USA

You are now leaving this website. 

By continuing, you will be directed to a site intended for residents inside the U.S. and Canada.

We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ USA